Rising Cardiovascular Disease Rates Drive Expansion Of Lisinopril Market Emerges as a Core Driver of the Lisinopril Market in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Lisinopril Market Through 2025?
A significant expansion has been observed recently within the lisinopril market, projecting an ascent from its 2024 valuation of $1.76 billion to $1.87 billion by 2025, reflecting a compound annual growth rate of 6.4%; this historical upward trajectory is mainly powered by broader availability, evolving lifestyle patterns, enhanced proactive health checks, greater ease in obtaining generic forms of lisinopril, and improved patient compliance with treatment regimens.

What's the Projected Size of the Global Lisinopril Market by 2029?
Anticipation is for substantial expansion within the lisinopril market across the forthcoming years, with its valuation projected to ascend to $2.35 billion by the year 2029, fueled by a compound annual growth rate (CAGR) of 5.9%. This upward trajectory during the projection timeframe stems from several key factors: an increasing incidence of hypertension and cardiovascular ailments, the accessibility and favorable pricing of generic alternatives, heightened public knowledge alongside earlier disease identification, a surging need for efficacious therapeutic options, and the demographic shift towards an older population. Furthermore, dominant patterns shaping this period involve advancements in how the medication is administered, the imperative for superior and more personalized drug delivery methodologies, the requirement for economical solutions, the need for robust treatments specifically targeting heart failure, and the demand for efficacious interventions against diabetic kidney disease.

View the full report here:
https://www.thebusinessresearchcompany.com/report/lisinopril-global-market-report

Top Growth Drivers in the Lisinopril Industry: What's Accelerating the Market?
The escalating incidence of ailments related to the heart and circulatory system is anticipated to fuel the expansion of the lisinopril market moving ahead. As a class of conditions impacting the heart and blood vessels, cardiovascular diseases (CVDs) are becoming more widespread, a trend linked to several societal shifts, including demographic expansion and an aging populace, alongside persistent modifiable risk factors and insufficient uptake of established preventative and therapeutic protocols. Lisinopril serves as a key treatment in managing these conditions principally by effectively decreasing blood pressure, thereby alleviating stress on both the cardiac muscle and the kidneys; its mechanism involves blocking the synthesis of angiotensin II, which promotes wider blood vessels, lowers circulating blood volume, and offers protective benefits to vital organs. To illustrate this critical public health concern, data from the Singapore Heart Foundation (SHF), a local non-profit, indicated that ischemic heart diseases accounted for 5,302 fatalities in May 2024, marking a marginal rise from the 5,290 deaths recorded in 2022, underscoring why the increasing burden of cardiovascular pathology is a major impetus for the lisinopril market's advancement.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16465&type=smp

What Are the Main Segments in the Lisinopril Market?
The lisinoprilmarket covered in this report is segmented -

1) By Brand: Zestoretic; Prinivil; Zestril; Other Brands
2) By Disease: Hypertension; Heart Failure; Heart Attack; Strokes; Diabetic Kidney Disease; Other Diseases
3) By Dosage: Tablet; Liquid; Other Dosages
4) By Population Type: Children; Adults
5) By End-Users: Hospitals; Specialty Clinics; Other End-Users

Subsegments:
1) By Zestoretic: Different Dosage Forms; Generic Versions Of Zestoretic
2) By Prinivil: Different Dosage Forms; Generic Versions Of Prinivil
3) By Zestril: Different Dosage Forms; Generic Versions Of Zestril
4) By Other Brands: International Brand Variants; Combination Drug Formulations

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16465&type=smp

Which Top Companies are Driving Growth in the Lisinopril Market?
Major companies operating in the lisinopril market are Merck & Co. Inc., Pfizer Inc., AbbVie Inc., AstraZeneca Plc, Vitaris Inc., Teva Pharmaceutical Industries Limited, Bausch Health Companies Inc., Hetero Ltd., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Amneal Pharmaceutical Inc., Lupin Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Metrochem API Private Limited, Calyx Chemicals & Pharmaceuticals Limited, Farmhispania Group, Zydus Cadila Healthcare Ltd., Qingdao Qingmei Biotech Co. Ltd., LGM Pharma LLC, Amara Labs Pvt., Sms Lifesciences

Which Regions Will Dominate the Lisinopril Market Through 2029?
North America was the largest region in the lisinopril market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16465

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.